Singapore markets closed
Straits Times Index
3,410.81 -29.07 (-0.85%) Nikkei
40,912.37 -1.28 (-0.00%) Hang Seng
17,799.61 -228.67 (-1.27%) FTSE 100
8,203.93 -37.33 (-0.45%) Bitcoin USD
56,953.78 +1,271.69 (+2.28%) CMC Crypto 200
1,181.57 -27.13 (-2.24%)
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (600196.SS)
Shanghai - Shanghai Delayed price. Currency in CNY
Add to watchlist
At close: 03:00PM CST
Currency in CNY
Valuation measures4
| Market cap (intra-day) | 52.84B |
| Enterprise value | 72.72B |
| Trailing P/E | 28.95 |
| Forward P/E | 17.76 |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 1.43 |
| Price/book (mrq) | 1.25 |
| Enterprise value/revenue | 1.79 |
| Enterprise value/EBITDA | 16.97 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.62 |
| 52-week change 3 | -29.70% |
| S&P500 52-week change 3 | 26.25% |
| 52-week high 3 | 32.08 |
| 52-week low 3 | 20.38 |
| 50-day moving average 3 | 23.23 |
| 200-day moving average 3 | 24.95 |
Share statistics
| Avg vol (3-month) 3 | 8.64M |
| Avg vol (10-day) 3 | 6.82M |
| Shares outstanding 5 | 2.12B |
| Implied shares outstanding 6 | 2.4B |
| Float 8 | 1.7B |
| % held by insiders 1 | 42.37% |
| % held by institutions 1 | 6.74% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | 0.42 |
| Forward annual dividend yield 4 | 1.93% |
| Trailing annual dividend rate 3 | 0.27 |
| Trailing annual dividend yield 3 | 1.24% |
| 5-year average dividend yield 4 | 1.16 |
| Payout ratio 4 | 56.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | 09 Aug 2023 |
| Last split factor 2 | 1.5:1 |
| Last split date 3 | 26 Jul 2010 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 4.94% |
| Operating margin (ttm) | 9.65% |
Management effectiveness
| Return on assets (ttm) | 0.61% |
| Return on equity (ttm) | 4.56% |
Income statement
| Revenue (ttm) | 40.69B |
| Revenue per share (ttm) | 15.26 |
| Quarterly revenue growth (yoy) | -6.60% |
| Gross profit (ttm) | N/A |
| EBITDA | 3.87B |
| Net income avi to common (ttm) | 2.01B |
| Diluted EPS (ttm) | 0.75 |
| Quarterly earnings growth (yoy) | -38.20% |
Balance sheet
| Total cash (mrq) | 15.02B |
| Total cash per share (mrq) | 5.62 |
| Total debt (mrq) | 34.9B |
| Total debt/equity (mrq) | 60.66% |
| Current ratio (mrq) | 1.01 |
| Book value per share (mrq) | 17.34 |
Cash flow statement
| Operating cash flow (ttm) | 3.46B |
| Levered free cash flow (ttm) | -2.51B |
© 2024 Yahoo. All rights reserved.